Who is acting director of the CDC now?
Leadership change and what it could mean for public health
The National Institutes of Health director has been appointed to run the Centers for Disease Control and Prevention on an acting basis while the administration searches for a permanent head. The temporary arrangement makes him the latest leader at the agency in a period of rapid turnover, and it places responsibility for national disease surveillance, outbreak response, and vaccination policy in the hands of a senior official who already heads another major federal science body.
Public health observers have voiced concern about the change because it concentrates high‑profile roles in one individual and comes amid growing debate over federal vaccine and pandemic policies. Supporters say the acting director brings administrative experience and scientific credentials; critics worry about potential conflicts in priorities between research functions at the NIH and operational public‑health duties at the CDC.
What to expect in the short term
- Continued management of active public‑health threats, including outbreaks and vaccination campaigns, under interim leadership.
- Close scrutiny from medical societies, state health departments, and lawmakers about any shifts in guidance or agency emphasis.
- Ongoing uncertainty until a permanent director is nominated and confirmed.
Questions remaining
- How long the acting role will last, and whether it will be followed by a swift permanent appointment.
- Whether interim leadership will change CDC priorities or workflows, particularly in areas like vaccine policy and disease surveillance.
For health professionals and the public, the immediate implication is heightened attention to CDC communications and a need to monitor how operational decisions are handled while leadership is in transition.